Maven Securities LTD - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 181 filers reported holding ADMA BIOLOGICS INC in Q2 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
Maven Securities LTD ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q1 2024$330,000
+99.4%
50,0000.0%0.02%
+533.3%
Q1 2023$165,500
+347.3%
50,000
+233.3%
0.00%
+200.0%
Q3 2022$37,000
-96.0%
15,000
-96.8%
0.00%
-96.4%
Q2 2022$929,000
-85.5%
469,206
-86.6%
0.03%
-87.4%
Q1 2022$6,389,000
+36.7%
3,491,524
+5.3%
0.22%
+65.7%
Q4 2021$4,675,000
+253.9%
3,315,607
+341.9%
0.13%
+127.1%
Q1 2021$1,321,000750,3250.06%
Other shareholders
ADMA BIOLOGICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Perceptive Advisors 33,169,604$53,072,0000.34%
Clearline Capital LP 922,517$1,476,0000.22%
GSA CAPITAL PARTNERS LLP 860,911$1,377,0000.16%
Prosight Management, LP 115,100$184,0000.12%
Banco BTG Pactual S.A. 92,500$148,0000.10%
Meridian Wealth Management, LLC 164,000$262,0000.03%
Shay Capital LLC 159,614$255,0000.03%
Signature Wealth Management Partners, LLC 10,500$17,0000.02%
XTX Topco Ltd 24,881$40,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 227,469$364,0000.01%
View complete list of ADMA BIOLOGICS INC shareholders